390 related articles for article (PubMed ID: 18534709)
21. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
23. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
24. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
25. [Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats].
Qiu JF; Wu ZY; Zhang ZQ; Luo HF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):428-31. PubMed ID: 15144673
[TBL] [Abstract][Full Text] [Related]
26. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
27. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
[TBL] [Abstract][Full Text] [Related]
28. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
[TBL] [Abstract][Full Text] [Related]
29. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
30. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
Feng H; Leng X; Zhang Z
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
33. Cytoprotective function of tetrahydrobiopterin in rat liver ischemia/reperfusion injury.
Hara Y; Teramoto K; Ishidate K; Arii S
Surgery; 2006 Mar; 139(3):377-84. PubMed ID: 16546503
[TBL] [Abstract][Full Text] [Related]
34. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
36. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.
Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT
J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827
[TBL] [Abstract][Full Text] [Related]
37. Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis.
Delgado MG; Gracia-Sancho J; Marrone G; Rodríguez-Vilarrupla A; Deulofeu R; Abraldes JG; Bosch J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G496-502. PubMed ID: 23886859
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
39. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
[TBL] [Abstract][Full Text] [Related]
40. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]